Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient high-dose chemotherapy with autologous peripheral blood stem cell support and single-dose pegfilgrastim in lymphoproliferative malignancies
2006-002971-42Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pegfilgrastim in lymphoma and Hematopathy, sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Mortality due to febrile neutropenia. Started Jul 2007; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
lymphomaHematopathy
Beyond the preview
Go deeper on 2006-002971-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002971-42.